Document is current
Any future updates will be listed below
-
Authors
Soltani, Iness http://orcid.org/0000-0002-8021-7802
von Renteln, Daniel http://orcid.org/0000-0002-6125-0068
- License Information
-
More Information
Article History
First Online: 15 April 2020
Compliance with Ethical Standards
:
: Daniel von Renteln is supported by a “Fonds de Recherche du Québec Santé” career development award. He has also received research funding from ERBE, Ventage, Pendopharm, and Pentax, and is a consultant for Boston Scientific and Pendopharm. Iness Soltani has no conflict of interest to declare.
